Stocktoria
DYADIC INTERNATIONAL INC DYAI
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2004-11-05
DYADIC INTERNATIONAL INC insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| TCHELET RONEN | VP of Research and Bus. Dvlpmt | 2026-01-02 | Grant | 18,064 | — |
| Rawson Ping Wang | Chief Financial Officer | 2026-01-02 | Grant | 29,158 | — |
| Lucy Patrick K. | director | 2026-01-02 | Option exercise | 21,552 | — |
| Kaye Jack | director | 2026-01-02 | Option exercise | 21,552 | — |
| HERBST SETH | director | 2026-01-02 | Option exercise | 21,552 | — |
| Hazelton Joseph P | President & COO | 2026-01-02 | Grant | 36,418 | — |
| EMALFARB MARK A | CEO | 2026-01-02 | Grant | 102,609 | — |
| Hazelton Joseph P | President and COO | 2025-08-01 | Buy | 26,000 | $0.95 |
Source: SEC EDGAR filings · CIK 0001213809 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.